Literature DB >> 2115418

Analysis of immunoglobulins secreted by hybridomas derived from rheumatoid synovia.

C M Brown1, C Plater-Zyberk, R A Mageed, R Jefferis, R N Maini.   

Abstract

Twenty-six IgG-secreting and eight IgM-secreting hybridomas were derived from the synovia of two patients with rheumatoid arthritis (RA). Hybridomas were obtained by fusing a heteromyeloma cell line, SPAZ-4 with synovial mononuclear cells that were not deliberately stimulated in vitro. Over 96% of the IgG-secreting hybridomas produced antibodies which belonged to the IgG1 subclass and showed lambda light chain predominance; the latter was not seen in IgM antibodies, where kappa light chains dominated by 3:1. All IgG antibodies were cationic. Synovial B cells were not exposed to extrinsic stimuli prior to fusion, therefore these results reflect the state of B cell activation and differentiation in vivo. Our results indicate that IgG-secreting B cells in the RA joint are under a selective influence which is, as yet, unidentified. One out of eight IgM-secreting and two out of 26 IgG-secreting hybridomas produced rheumatoid factors (RF). The IgM-RF specificity for IgG heavy chain subclasses was determined and showed that the monoclonal bound to IgG1, IgG2 and IgG4 but not IgG3 with exception of IgG3 Goe of the G3m (st) allotype, a profile typical of specificity for the Ga epitope. This monoclonal also distinguished a determinant in the Fc region of human IgG which was not present in rabbit IgG. The overall frequency of RF-secreting hybridomas we observed indicates that B cells committed to RF production in the synovium of a seropositive and a seronegative RA patient is below 10%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115418      PMCID: PMC1535208          DOI: 10.1111/j.1365-2249.1990.tb03294.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  TWO TYPES OF 6.6 S GAMMA-GLOBULINS, BETA-2A-GLOBULINS AND 18 S GAMMA 1-MACROGLOBULINS IN NORMAL SERUM AND GAMMA-MICROGLOBULINS IN NORMAL URINE.

Authors:  J L FAHEY
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

2.  Hidden rheumatoid factors with specificity for native gamma globulins.

Authors:  J C Allen; H G Kunkel
Journal:  Arthritis Rheum       Date:  1966-12

3.  In vivo synthesis of IgG by rheumatoid synovium.

Authors:  A J Sliwinski; N J Zvaifler
Journal:  J Lab Clin Med       Date:  1970-08

4.  IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.

Authors:  M Mayumi; T Kuritani; H Kubagawa; M D Cooper
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

5.  Abnormalities in isotype expression in CBA/N mice due to stimulatory environment rather than a B cell defect.

Authors:  J M Teale
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates.

Authors:  F Ebling; B H Hahn
Journal:  Arthritis Rheum       Date:  1980-04

7.  Kappa:lambda light chain ratio in IgG eluted from rheumatoid arthritis synovium.

Authors:  F D Lindström
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

8.  In vitro synthesis of immunoglobulin by rheumatoid synovial membrane.

Authors:  J D Smiley; C Sachs; M Ziff
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Immunoglobulin G3 subclass production by rheumatoid synovial tissue cultures.

Authors:  W L Hoffman; M S Goldberg; J D Smiley
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  T cell regulation of IgG subclass antibody production in response to T-independent antigens.

Authors:  P K Mongini; K E Stein; W E Paul
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  8 in total

1.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells.

Authors:  Edgar D Charles; Michael I M Orloff; Lynn B Dustin
Journal:  J Immunol Methods       Date:  2010-09-24       Impact factor: 2.303

3.  A human monoclonal IgA rheumatoid factor using the VkIV light chain gene.

Authors:  R Mierau; A Gause; R Küppers; M Michels; R A Mageed; R Jefferis; E Genth
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  Immortalized B-lymphocytes from rheumatoid synovial tissue show specificity for bacterial HSP 60.

Authors:  V Krenn; H P Vollmers; P von Landenberg; B Schmausser; M Rupp; A Roggenkamp; H K Müller-Hermelink
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

5.  Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF-AN) and the Fc fragment of human IgG4.

Authors:  M K Sohi; A L Corper; T Wan; M Steinitz; R Jefferis; D Beale; M He; A Feinstein; B J Sutton; M J Taussig
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

6.  Sequence analysis of immunoglobulin heavy-chain variable region genes from the synovium of a rheumatoid arthritis patient shows little evidence of mutation but diverse CDR3.

Authors:  C M Brown; K J Fitzgerald; S P Moyes; R A Mageed; D G Williams; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue.

Authors:  C M Brown; C Longhurst; G Haynes; C Plater-Zyberk; A Malcolm; R N Maini
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.